is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The European Pharmacopeia clearly defines the pathogenic bacteria that cannot be present in the Medical Devices because they could affect the human body system, causing Hospital Acquired Infections. However, in recent years, the excessive use of antibiotics, disinfectants and preservatives has exposed patients and care givers to an increasing risk of infection from non-pathogenic organisms. These bacteria are defined “opportunistic or objectionable organisms”.
The threat varies in accordance to the susceptibility of the person to develop an infection after exposure to an organism. The higher likelihood of infection is reflected in vulnerable patients who are immunocompromised because of underlying disease, severity of illness, immunosuppressive medications, and surgical treatment.
This underlines the major role of the caregiver whose responsibility is to properly select the Medical Device to be used based on the severity of the patient’s conditions and the guarantee of minimal presence of objectionable organism in the product.
Welcare Industries Spa will take the opportunity of Africa Health 2017 to introduce two different solutions to deal with HAIs challange: